NEW YORK, NY, June 16, 2022 (GLOBE NEWSWIRE) -- Facts and Factors has published a new research report titled “Breast Biopsy Market - Global & Regional Industry Perspective, Comprehensive Analysis, and Forecast 2022 – 2028” in its research database.
“According to the latest research study, the demand of global Breast Biopsy Market size & share in terms of revenue was worth of USD 702.13 million in 2021 and it is expected to hit around USD 1,109.35 million Mark, by 2028, growing at a compound annual growth rate (CAGR) of about 7.3% during the forecast period 2022 to 2028.”
What is Breast Biopsy? How big is the Breast Biopsy Market?
Market Overview:
A diagnostic procedure known as a breast biopsy is performed on a small tissue sample taken from the breast in order to establish the presence or absence of cancer in the breast. It is widely acknowledged as being among the most successful approaches to detecting cancer. Even though 70–80 percent of biopsies show no signs of cancer, there is still a possibility that they will develop breast carcinoma in the future. When a person has symptoms such as a breast lump, sore breast, breast dimpling, peeling of the breast, and nipple discharge, a breast biopsy is recommended. Due to the rising incidence of breast cancer all over the world and the fact that breast biopsies are the least invasive method, the market for breast biopsies has expanded in recent years.
Get a Free Sample PDF of this Research Report for more Insights with a Table of Content, Research Methodology, and Graphs - https://www.fnfresearch.com/sample/breast-biopsy-market
(A free sample of this report is available upon request; please contact us for more information.)
Our Free Sample Report Consists of the Following:
- Introduction, Overview, and in-depth industry analysis are all included in the 2022 updated report.
- The COVID-19 Pandemic Outbreak Impact Analysis is included in the package
- About 227+ Pages Research Report (Including Recent Research)
- Provide detailed chapter-by-chapter guidance on Request
- Updated Regional Analysis with Graphical Representation of Size, Share, and Trends for the Year 2022
- Includes Tables and figures have been updated
- The most recent version of the report includes the Top Market Players, their Business Strategies, Sales Volume, and Revenue Analysis
- Facts and Factors research methodology
(Please note that the sample of this report has been modified to include the COVID-19 impact study prior to delivery.)
Report Scope
| Report Attribute | Details |
| Market Size in 2021 | USD 702.13 Million |
| Projected Market Size in 2028 | USD 1,109.35 Million |
| CAGR Growth Rate | 7.3% CAGR |
| Base Year | 2021 |
| Forecast Years | 2022-2028 |
| Key Market Players | Hologic, Inc. (US), Becton, Dickinson and Company (US), Danaher Corporation (US), Merit Medical Systems (US), Medtronic (Ireland), IZI Medical Products (US), Argon Medical (US), STERYLAB S.r.l. (Italy), Scion Medical Technologies, LLC (China), QIAGEN (Netherlands), Biocept Inc. (US), Bio-Rad Laboratories, Inc. (US), F. Hoffmann-La Roche Ltd (Switzerland), Menarini Silicon Biosystems, Spa (Italy), Exact Sciences Corporation (US), Thermo Fisher Scientific, Inc. (US), Cardiff Oncology, Inc. (US), Myriad Genetics, Inc. (US), Illumina, Inc. (US), Fluxion Biosciences Inc (US), and Others |
| Key Segment | By Product, Type, Guidance, Application, and Region |
| Major Regions Covered | North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
| Purchase Options | Request customized purchase options to meet your research needs. Explore purchase options |
Global Breast Biopsy Market: Dynamics
Breast biopsy market expansion is fuelled by the growing sensitivity of women to mammary cancer in all nations, as well as awareness initiatives and screenings conducted in their favor. The biopsy market has grown as a result of a broad and vigorous research environment, which has contributed to the development of more accurate and minimally invasive treatments for the early detection of breast cancer. Governments have also made efforts to foster a stable and comprehensive environment for cancer research, which has aided in the development of these diagnostic tools.
Additionally, favorable reimbursements have substantially improved the health of this sector. The significant market expansion throughout the study period can be due to new product approvals and launches, as well as a growing desire for less invasive and graphics-based needle biopsies (such as vacuum-assisted biopsy and core needle biopsy). The occurrence of side effects and infections following biopsy stymies the growth of these diagnostic tools.
Browse the full “Breast Biopsy Market By Product (Biopsy Needles, Guidance Systems, Biopsy Tables, Localization Wires, Assay Kits, Liquid Biopsy Instruments, Others), By Type (Needle Breast Biopsy, Core Needle Biopsy (CNB), Fine Needle Aspiration Biopsy (FNAB), Vacuum-assisted Biopsy (VAB), Open Surgical Breast Biopsy, Excisional, Incisional, Liquid Breast Biopsy, Circulating Tumor Cells, Circulating Tumor DNA (CtDNA), Other Biomarkers), By Guidance (Image-Guided Biopsy, Mammography-guided Stereotactic Biopsy, Ultrasound-guided Biopsy, MRI-guided Biopsy, Other Guidance Techniques, Liquid Biopsy, NGS-based Biopsy, PCR-based Biopsy, Microarray-based Biopsy), By Application (Early Cancer Screening, Therapy Selection, Treatment Monitoring, Recurrence Monitoring), and By Region - Global Industry Insights, Growth, Size, Share, Comparative Analysis, Trends and Forecast 2022 – 2028” Report at https://www.fnfresearch.com/breast-biopsy-market
Breast Biopsy Market: COVID-19 Impact Analysis
The widespread spread of the coronavirus and the subsequent isolation have likely had an effect on a range of industries, one of which is the market for breast biopsy. The development of brand-new policies, standards, and laws is acting as a brake on the growth of this sector's economy. In addition, restricted access to clinics, social isolation, and population lockdown, all of which lead to a reduction in the rate of patient flow and referrals, have all had an effect on the expansion of the market. The widespread development of COVID has forced the postponement of a number of planned surgical procedures.
Because surgical procedures increase the likelihood of infection, medical professionals have been forced to make the challenging choice to delay elective surgery. During the pandemic, there was a probability of COVID infection, which meant that any potential delays in cancer detection or treatment could result in life-threatening circumstances. This delicate balancing act had to be performed. During the early phases of the pandemic, this was the challenge that proved to be the most challenging to overcome.
Breast Biopsy Market: Segmentation Analysis
The global Coconut Water market is segregated based on Product, Type, Guidance, and Application.
In terms of Product, the biopsy needles segment is likely to hold a significant share of the breast biopsy market because of the increasing acceptance of image-guided techniques in both developed and developing nations, as well as the introduction of technologically advanced and unique designs. For example, consider the tri-axial needle, which is made up of a pincer needle on the outside, an outer cutting needle, and a sharp stylet on the inside. Due to the needle design, healthcare providers can cut through tissue without squeezing it. Even with its unique form, the needle is easily visible under ultrasonography and CT, which are often used for biopsy guiding.
In terms of Guidance, the liquid biopsy category is expected to expand the most during the projection period. Liquid biopsy has emerged as a game-changing method that is expanding the scope of oncology diagnoses. The considerable rise of the segment can be attributable to the increasing usage of innovative NGS-based assays and droplet digital PCR technology in most developed countries for performing liquid biopsies. Companies in the industry are investing more in research and development in order to bring new items to market. As a result, continuing clinical trials and a potential product pipeline will push market growth even further.
Directly Purchase a copy of the report with TOC @ https://www.fnfresearch.com/buynow/su/breast-biopsy-market
Competitive Landscape
Some of the main competitors dominating the global Breast Biopsy market include -
- Hologic, Inc. (US)
- Becton, Dickinson and Company (US)
- Danaher Corporation (US)
- Merit Medical Systems (US)
- Medtronic (Ireland)
- IZI Medical Products (US)
- Argon Medical (US)
- STERYLAB S.r.l. (Italy)
- Scion Medical Technologies
- LLC (China)
- QIAGEN (Netherlands)
- Biocept Inc. (US)
- Bio-Rad Laboratories, Inc. (US)
- F. Hoffmann-La Roche Ltd (Switzerland)
- Menarini Silicon Biosystems, Spa (Italy)
- Exact Sciences Corporation (US)
- Thermo Fisher Scientific, Inc. (US)
- Cardiff Oncology, Inc. (US)
- Myriad Genetics, Inc. (US)
- Illumina, Inc. (US)
- Fluxion Biosciences Inc (US)
Key Insights from Primary Research:
- As per the analysis shared by our research analyst, the Breast Biopsy market is estimated to grow at a CAGR of around 7.3% over the forecast period (2022-2028).
- In Terms Of Revenue, the Breast Biopsy market was valued at around USD 702.13 million in 2021 and is projected to reach USD 1,109.35 million, by 2028. Due to a variety of driving factors, the market is predicted to rise at a significant rate.
- Based on Guidance, the stereotactic breast biopsy is gaining a significant share in the forecast period.
- Based on Product, the biopsy needles segment is likely to hold a significant share of the breast biopsy market because of the increasing acceptance of image-guided techniques in both developed and developing nations.
- On the basis of region, the North America now dominates the market share, accounting for more of a major share in the forecast period.
Have Any Query? Ask Our Experts: https://www.fnfresearch.com/inquiry/breast-biopsy-market
Key questions answered in this report:
- What is the market size and growth rate forecast for Breast Biopsy industry?
- What are the main driving factors propelling the Breast Biopsy Market forward?
- What are the leading companies in the Breast Biopsy Industry?
- What segments does the Breast Biopsy Market cover?
- How can I receive a free copy of the Breast Biopsy Market sample report and company profiles?
Regional Dominance:
The breast biopsy market in the Asia Pacific is expected to develop the fastest. The healthcare infrastructure in growing economies such as China, India, and South Korea is rapidly evolving, prompting hospitals and breast care centers to make significant expenditures on modern systems (such as liquid breast biopsy and vacuum-assisted biopsy devices, among others). This reason is propelling the Asia Pacific breast biopsy market forward.
Furthermore, rising breast cancer prevalence, an increase in the number of breast cancer awareness initiatives, and increased government investment in breast cancer research studies are the primary drivers driving the growth of the Asia Pacific breast biopsy market.
Request for Customization on this Report as per your requirements - https://www.fnfresearch.com/customization/breast-biopsy-market
(We tailor your report to meet your specific research requirements. Inquire with our sales team about customising your report.)
The global breast biopsy market is segmented as follows:
By Product
- Biopsy Needles
- Guidance Systems
- Biopsy Tables
- Localization Wires
- Assay Kits
- Liquid Biopsy Instruments
- Others
By Type
- Needle Breast Biopsy
- Core Needle Biopsy (CNB)
- Fine Needle Aspiration Biopsy (FNAB)
- Vacuum-assisted Biopsy (VAB)
- Open Surgical Breast Biopsy
- Excisional
- Incisional
- Liquid Breast Biopsy
- Circulating Tumor Cells
- Circulating Tumor DNA (CtDNA)
- Other Biomarkers
By Guidance
- Image-Guided Biopsy
- Mammography-guided Stereotactic Biopsy
- Ultrasound-guided Biopsy
- MRI-guided Biopsy
- Other Guidance Techniques
- Liquid Biopsy
- NGS-based Biopsy
- PCR-based Biopsy
- Microarray-based Biopsy
By Application
- Early Cancer Screening
- Therapy Selection
- Treatment Monitoring
- Recurrence Monitoring
By Region
- North America
- U.S.
- Canada
- Rest of North America
- Europe
- France
- UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Rest of Asia Pacific
- The Middle East & Africa
- Saudi Arabia
- South Africa
- Rest of the Middle East & Africa
- Latin America
- Brazil
- Argentina
- Rest of Latin America
To know an additional revised 2022 list of market players, request a sample report: https://www.fnfresearch.com/sample/breast-biopsy-market
Browse Other Related Research Reports from Facts & Factors:
Blood Filters Market By Product (40 Microns and 70 Microns, 100 Microns and 170 Microns, Others), By Material (Polycarbonate, Polyester, ABS), By Application (Blood Processing, Blood Transfusion), By End-User (Blood Banks, Hospitals, Others), and By Region - Global Insights, Growth, Size, Comparative Analysis, Trends and Forecast 2022 – 2028
Cold Plasma Market By Industry (Medical Industry, Textile Industry, Plastic & Polymer Industry, and Others), By Regime (Low-Pressure Cold Plasma and Atmospheric Cold Plasma), and By Region - Global and Regional Industry Trends, Competitive Intelligence, Analysis of Data, Statistical Data, and Forecast 2022-2028
Drug Delivery in Cancer Market By Product (Liposome, PE Gylated Proteins & Polypeptides, Polymer Nanoparticle, Protein–drug Conjugates), By Application (Hospitals & Clinic, Cancer Treatment Centers, Others), and By Region - Global Industry Overview, Market Size, Share, Statistical Research, Market Intelligence, Comprehensive Analysis, Trends, and Forecast 2022–2028
Radiopharmaceutical Market By Type (Therapeutic and Diagnostic), By Application (Cardiology, Oncology, Neurology, and Others), By End-User (Diagnostic Centers, Hospitals & Clinics, and Others), and By Region-Global and Regional Industry Overview, Comprehensive Analysis, Competitive Intelligence, Statistical Evidence, and Forecast 2022–2028
Blood Pressure Monitoring Devices Market By Product (Ambulatory Blood Pressure Monitor, Digital Blood Pressure Monitor, Sphygmomanometer, Transducers, and Instruments & Accessories), By End-User (Home Healthcare, Hospitals, Ambulatory Surgical Centers & Clinics), and By Region-Global and Regional Market Dynamics, Data Analytics, Consumer Demand, Statistical Surveys, Extensive Research, Historical Trends, Current Patterns, and Forecast 2022–2028
Anti-Neoplastic Agents Market By Type of Product (Biological Agents, Personalized Medicine, and Chemotherapeutic Agents), By End-User (Cancer Rehabilitation Centers, Clinics, Hospitals, and Ambulatory Surgical Centers), and By Region-Global and Regional Industry Overview, Market Insights, Holistic Investigation, Historical Information, and Forecast 2022–2028
About Facts & Factors:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds.
Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Follow Us on LinkedIn: https://www.linkedin.com/company/fnfresearch
Follow Us on Twitter: https://twitter.com/fnfresearch
Follow Us on Facebook: https://www.facebook.com/factsandfactors/
Contact Us:
Sanu Thomas
USA: +1 347 690-0211
United Kingdom: +44 2032 894158
Japan: +81 50 5806 9039
India: +91 96043 17127
Email: sales@fnfresearch.com
Web: https://www.fnfresearch.com
Blog: https://www.fnfresearch.com/blog/
